Carolina P. Schroder
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.
Journal: JAMA oncology
Published: April 16, 2026
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: February 06, 2026
Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 01, 2026
Interassay Comparison With Digital Image Analysis of 4 Routine Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry Assays in Primary Breast Cancer and Its Metastasis.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: August 27, 2025
Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 11, 2025
Intrapatient 16α-[18F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 16, 2024
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 19, 2024
Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: December 18, 2023
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2023
Molecular imaging as biomarker for treatment response and outcome in breast cancer.
Journal: Therapeutic advances in medical oncology
Published: September 29, 2022
Clinical Validity of 16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 18, 2022
Last Updated: 09/26/2026